D.A. Davidson & CO. Boosts Holdings in MetLife, Inc. (NYSE:MET)

D.A. Davidson & CO. lifted its stake in shares of MetLife, Inc. (NYSE:MET) by 3.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 22,294 shares of the financial services provider’s stock after buying an additional 671 shares during the quarter. D.A. Davidson & CO.’s holdings in MetLife were worth $1,839,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. PFG Investments LLC lifted its stake in shares of MetLife by 8.9% in the 3rd quarter. PFG Investments LLC now owns 6,360 shares of the financial services provider’s stock valued at $525,000 after purchasing an additional 520 shares during the period. M&G Plc bought a new stake in shares of MetLife during the 2nd quarter valued at $2,346,000. B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in shares of MetLife in the 3rd quarter worth about $2,960,000. PGGM Investments increased its stake in shares of MetLife by 1,803.4% in the 2nd quarter. PGGM Investments now owns 69,796 shares of the financial services provider’s stock worth $4,899,000 after acquiring an additional 66,129 shares in the last quarter. Finally, Segall Bryant & Hamill LLC purchased a new position in MetLife during the 3rd quarter valued at about $1,074,000. 89.81% of the stock is owned by institutional investors.

MetLife Price Performance

NYSE MET opened at $88.23 on Friday. The stock has a market capitalization of $61.09 billion, a price-to-earnings ratio of 17.79, a PEG ratio of 0.81 and a beta of 1.05. MetLife, Inc. has a 1-year low of $63.02 and a 1-year high of $89.05. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The business’s fifty day moving average price is $83.34 and its 200-day moving average price is $76.59.

MetLife Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Tuesday, November 5th will be given a $0.545 dividend. The ex-dividend date is Tuesday, November 5th. This represents a $2.18 annualized dividend and a yield of 2.47%. MetLife’s payout ratio is 43.95%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on MET shares. TD Cowen raised their target price on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday. Wells Fargo & Company lifted their price objective on MetLife from $92.00 to $93.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. Piper Sandler increased their target price on MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 2nd. Jefferies Financial Group lifted their price target on MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a research report on Friday, September 27th. Finally, Barclays reduced their price objective on shares of MetLife from $91.00 to $90.00 and set an “overweight” rating for the company in a research note on Thursday, October 31st. Fourteen investment analysts have rated the stock with a buy rating, According to data from MarketBeat, MetLife has an average rating of “Buy” and an average target price of $88.62.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.